Optional analytics, advertising and case-study videos are off. Allow them all, or open settings to choose. Privacy policy

Max Tymoshyn, founder of Norml Studio
Max TymoshynFounder, Norml Studio

Decide what the biotech website needs to explain to each reader.

An investor evaluating the company, a partner assessing the platform and a scientist checking the evidence need different levels of detail. Norml defines the public website’s role for each audience, including the information the company is prepared to disclose and the next conversation it can support.

A few clients we’ve worked with

99Legal / Kremenchuker Law GroupAstraZenecaCoxitDiet vs DiseaseFlorida seal — Regional Counsel projectMetroplex HomebuyersNasdaq Private MarketOffice of Criminal Conflict and Civil Regional Counsel, Second Region of Florida — Ita M. NeymotinPolaclubThe Farm Soho

What we do

Website strategy for biotech companies: audience decisions, public evidence, website priorities.

Decisions for the biotech website.

  • Which audience decisions should the first release support?

  • Which platform and programme details are cleared for public disclosure?

What a plan prevents.

A website project needs more than a list of pages. Without the decisions written down, they get made later, by whoever happens to be in the meeting.

Design and build stop stalling

Missing decisions are identified and resolved in planning, so production is not waiting on an answer nobody owns.

The brief outlives the project

An agreed, documented direction means the next team — yours or ours — can work against the same reference.

Scope arguments have a referee

When the direction is written down, a late request can be measured against it instead of quietly absorbed.

Website strategy: scope of work.

The brief identifies the public information, website functions and review responsibilities included in the engagement.

Audience decisions

Map the questions that belong to investors, potential partners, scientists and candidates. Give each route a specific purpose.

Public evidence

Identify approved platform explanations, team information and publications. Record gaps that need a scientific or communications owner.

Website priorities

Agree the first release, contact destinations and editorial responsibilities against the team’s actual capacity.

What clients say.

Reviews from the companies we have built and maintained websites for.

Read every review on Clutch
“We didn’t choose them to be impressed — we chose them because we knew they’d deliver high-level results with no risk. As a CTO myself, that’s exactly what I look for in a long-term partnership.”
Iryna MykytynFounder & CTO, COXIT.COClutch review
“And, you know, the great part about the fact that you hit the goal, it's not that you had to compromise anything that you were doing, because, honestly, the end result far exceeded what we could have imagined.”
Chris NeeckChief Distribution Officer, InsuraTec
“I would just say that you deliver on quality … I just thought we clicked, and you delivered what we were looking for.”
Amanda GrayManager, Data and Financial Products, Nasdaq Private Market
“Norml Studio's professionalism and responsiveness were impressive.”
Josiah BallCo-Founder & CEO, HOMEECClutch review

What you receive.

These deliverables are prepared for the agreed website scope.

  1. 01

    An audience and decision map.

  2. 02

    A public-information and evidence inventory.

  3. 03

    A website brief with release priorities and owners.

Our process

How the work runs.

Gather priorities

Review the questions fielded by the partnering, communications and scientific teams.

[ 01 ]

Map the public story

Connect those questions with material the company can publish.

[ 02 ]

Agree the brief

Set the release scope and assign unresolved disclosure or content decisions.

[ 03 ]

The people who do this work.

No account layer between you and them. These are the Norml specialists this work runs through.

Meet the whole team
Max Tymoshyn, founder of Norml Studio

Let's chat

“I've spent 10 years working across development and marketing. I started as a developer, but design, SEO and advertising were already part of the job. That taught me to treat a website as one system: the business, the content, the design and the code have to work together. At Norml, I lead the architecture behind our work and stay involved wherever strategy, design, development and search meet.”

Max TymoshynFounder & Architect

Get started

Website strategy for biotech companies: questions.

Does an early-stage company need a large site?
The page count follows available information and audience needs. A focused platform explanation, team section and relevant contact route may be the appropriate first release.
Will you decide what research should be disclosed?
No. The company’s authorized reviewers decide disclosure; the brief records their decisions and the resulting website scope.
Website 2.0 combines strategy, design, development and launch in one engagement.

Planning the wider biotech website?

See Website 2.0